Hologic (HOLX) PT Lowered to $75 at Morgan Stanley

February 3, 2022 1:33 AM

Morgan Stanley analyst David Lewis lowered the price target on Hologic (NASDAQ: HOLX) to $75.00 (from $76.00) while maintaining a Equalweight rating.

No results found